OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From structure to the dynamic regulation of a molecular switch: A journey over 3 decades
Susan S. Taylor, Jian Wu, Jessica Bruystens, et al.
Journal of Biological Chemistry (2021) Vol. 296, pp. 100746-100746
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update
Robert Roskoski
Pharmacological Research (2022) Vol. 187, pp. 106552-106552
Open Access | Times Cited: 246

Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 update
Robert Roskoski
Pharmacological Research (2021) Vol. 175, pp. 106037-106037
Closed Access | Times Cited: 190

Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
Robert Roskoski
Pharmacological Research (2024) Vol. 200, pp. 107059-107059
Open Access | Times Cited: 180

Protein Data Bank: A Comprehensive Review of 3D Structure Holdings and Worldwide Utilization by Researchers, Educators, and Students
S.K. Burley, Helen M. Berman, José M. Duarte, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1425-1425
Open Access | Times Cited: 66

Targeting BCR-Abl in the treatment of Philadelphia-chromosome positive chronic myelogenous leukemia
Robert Roskoski
Pharmacological Research (2022) Vol. 178, pp. 106156-106156
Closed Access | Times Cited: 46

Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas
Robert Roskoski
Pharmacological Research (2024) Vol. 203, pp. 107181-107181
Open Access | Times Cited: 11

CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug Targets
Wengang Zhang, Yonglan Liu, Hyunbum Jang, et al.
JACS Au (2024) Vol. 4, Iss. 5, pp. 1911-1927
Open Access | Times Cited: 10

Phospho-relay feedback loops control egress vs. intracellular development in Toxoplasma gondii
Ja E. Claywell, Yong Fu, L. David Sibley
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115260-115260
Open Access | Times Cited: 1

Autophagy regulates neuronal excitability by controlling cAMP/protein kinase A signaling at the synapse
Melina Overhoff, Frederik Tellkamp, Simon Heß, et al.
The EMBO Journal (2022) Vol. 41, Iss. 22
Open Access | Times Cited: 31

Novel LRR-ROC Motif That Links the N- and C-terminal Domains in LRRK2 Undergoes an Order–Disorder Transition Upon Activation
Jui-Hung Weng, Chiara R. Trilling, Pallavi Kaila Sharma, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 167999-167999
Open Access | Times Cited: 22

How many kinases are druggable? A review of our current understanding
Brian Anderson, Peter Rosston, Han Wee Ong, et al.
Biochemical Journal (2023) Vol. 480, Iss. 16, pp. 1331-1363
Open Access | Times Cited: 21

The “violin model”: Looking at community networks for dynamic allostery
Lalima K. Madan, Colin L. Welsh, Alexandr P. Kornev, et al.
The Journal of Chemical Physics (2023) Vol. 158, Iss. 8
Open Access | Times Cited: 20

Protein structure–function continuum model: Emerging nexuses between specificity, evolution, and structure
Munishwar N. Gupta, Vladimir N. Uversky
Protein Science (2024) Vol. 33, Iss. 4
Closed Access | Times Cited: 7

A comprehensive exploration of the druggable conformational space of protein kinases using AI-predicted structures
Noah B. Herrington, Yan Chak Li, David Stein, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 7, pp. e1012302-e1012302
Open Access | Times Cited: 7

Looking lively: emerging principles of pseudokinase signaling
Joshua B. Sheetz, Mark A. Lemmon
Trends in Biochemical Sciences (2022) Vol. 47, Iss. 10, pp. 875-891
Open Access | Times Cited: 28

TOR complex 2 is a master regulator of plasma membrane homeostasis
Jeremy Thorner
Biochemical Journal (2022) Vol. 479, Iss. 18, pp. 1917-1940
Open Access | Times Cited: 23

Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States
Robert Roskoski
Pharmacological Research (2023) Vol. 194, pp. 106847-106847
Open Access | Times Cited: 15

Epigenetic control of circadian clocks by environmental signals
Xiao‐Lan Liu, Zeyu Duan, Muqun Yu, et al.
Trends in Cell Biology (2024)
Closed Access | Times Cited: 5

The cAMP-PKA signalling crosstalks with CWI and HOG-MAPK pathways in yeast cell response to osmotic and thermal stress
Fiorella Galello, Mariana Bermúdez Moretti, María Clara Ortolá Martínez, et al.
Microbial Cell (2024) Vol. 11, pp. 90-105
Open Access | Times Cited: 5

The structures of protein kinase A in complex with CFTR: Mechanisms of phosphorylation and noncatalytic activation
Karol Fiedorczuk, I Iordanov, Csaba Mihályi, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 46
Open Access | Times Cited: 5

Yeast Protein Kinase A Isoforms: A Means of Encoding Specificity in the Response to Diverse Stress Conditions?
Declan R. Creamer, Simon J. Hubbard, Mark Ashe, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 958-958
Open Access | Times Cited: 17

Soluble cyclase-mediated nuclear cAMP synthesis is sufficient for cell proliferation
Alejandro Pizzoni, Xuefeng Zhang, Nyla Naim, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 4
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top